Calcitonin-gene related peptide antagonist therapy associated with microvascular complications in patients with Raynaud’s Phenomenon
1. Microvascular complications were uncommon but nevertheless observed when individuals with Raynaud’s phenomenon (RP) or scleroderma were treated with Calcitonin-gene ...